A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients

Clinical trial NCT01764022 · COMPLETED

Trial details

NCT number: NCT01764022
Sponsor: Biocad
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Human Epithelial Receptor (HER)-2 Positive Breast Cancer

Start date: 2012-10-01
Primary completion: 2015-03-01
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.